Cork University Maternity Hospital

The medical center is at the forefront of neonatal pulmonology, focusing on innovative treatments for chronic lung disease in extremely premature infants. The center's research aims to reduce the incidence of severe bronchopulmonary dysplasia (BPD) and improve survival rates.

• Chronic Lung Disease in Premature Infants
• Bronchopulmonary Dysplasia (BPD) Management

Through cutting-edge clinical trials, the center is pioneering new therapeutic approaches that promise to enhance the quality of life for affected infants.

Specializing in oncologic dermatology, the center conducts advanced research on cutaneous squamous cell carcinoma (CSCC). The focus is on improving disease-free survival rates through adjuvant therapies post-surgery and radiation.

• High-Risk Cutaneous Squamous Cell Carcinoma
• Adjuvant Therapy Innovations

The center's work is instrumental in developing new standards of care that aim to reduce recurrence and improve patient outcomes.

In the field of neonatal resuscitation, the center explores optimal oxygenation strategies for very low birthweight infants. Research is directed towards understanding the impact of oxygen concentration on neurodevelopmental outcomes.

• Optimal Oxygenation Strategies
• Neurodevelopmental Outcomes in Premature Infants

This research is crucial in refining resuscitation protocols to enhance long-term developmental prospects for preterm infants.

The center is a leader in neonatal cardiology, particularly in the management of patent ductus arteriosus (PDA) in extremely low birth weight infants. The focus is on early targeted treatment to prevent complications such as intraventricular hemorrhage and necrotizing enterocolitis.

• Patent Ductus Arteriosus Management
• Prevention of Neonatal Complications

By advancing treatment protocols, the center aims to significantly improve survival and health outcomes for these vulnerable infants.